Graham Capital Management, L.P. Theravance Biopharma, Inc. Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 36,364 shares of TBPH stock, worth $335,639. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,364
Previous 30,756
18.23%
Holding current value
$335,639
Previous $247,000
38.46%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding TBPH
# of Institutions
128Shares Held
46.3MCall Options Held
600Put Options Held
300-
Madison Avenue Partners, LP New York, NY9.51MShares$87.8 Million14.29% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$68.8 Million2.02% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$43.9 Million9.1% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$34.9 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$25.5 Million2.79% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $616M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...